Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.

Author
:
KE Van Kessel
KA van der Keur
L Dyrskjøt
F Algaba
NY Welvaart
W Beukers
U Segersten
B Keck
T Maurer
T Simic
M Horstmann
MO Grimm
GG Hermann
K Mogensen
A Hartmann
N Harving
AC Petersen
JB Jensen
K Junker
JL Boormans
FX Real
N Malats
PU Malmström
TF Ørntoft
EC Zwarthoff
Abstract
:

The European Association of Urology (EAU) guidelines for non-muscle invasive bladder cancer (NMIBC) recommend risk stratification based on clinicopathological parameters. Our aim was to investigate the added value of biomarkers to improve risk stratification of NMIBC.
Year of Publication
:
2018
Journal
:
Clinical cancer research : an official journal of the American Association for Cancer Research
Date Published
:
2018
ISSN Number
:
1078-0432
URL
:
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=29367430
DOI
:
10.1158/1078-0432.CCR-17-2719
Short Title
:
Clin Cancer Res
Download citation